Company Filing History:
Years Active: 2025
Title: Na Wang: Innovator in Antibody Research
Introduction
Na Wang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of antibody research, focusing on therapeutic and diagnostic applications. With a total of 2 patents, his work has the potential to impact various medical treatments.
Latest Patents
Na Wang's latest patents include innovative antibodies specific to folate receptor alpha, also known as folate receptor 1 or FOLR1. These antibodies have applications in both therapeutic and diagnostic purposes. Additionally, he has developed chimeric antigen receptors (CARs) that incorporate an extracellular antigen-binding fragment targeting FOLR1, along with immune cells expressing these receptors. Another notable patent involves antibodies specific to MUC18, also referred to as MCAM or CD146. This patent includes antibody-drug conjugates (ADCs) that utilize these anti-MUC18 antibodies for therapeutic and diagnostic applications.
Career Highlights
Na Wang is currently associated with Multitude, Inc., where he continues to advance his research in antibody development. His work is characterized by a commitment to innovation and a focus on improving medical outcomes through targeted therapies.
Collaborations
Na Wang collaborates with esteemed colleagues, including Bing Hou and Xun Meng, who contribute to his research endeavors. Their combined expertise enhances the potential for groundbreaking discoveries in the field of antibody research.
Conclusion
Na Wang's contributions to antibody research exemplify the innovative spirit of modern science. His patents and collaborations position him as a key figure in the development of new therapeutic and diagnostic tools.